262 related articles for article (PubMed ID: 12759497)
1. Mutations in exon 11 of the c-kit gene in a myogenic tumor and a neurogenic tumor as well as in gastrointestinal stromal tumors. Utility of c-kit mutation as a prognostic biomarker for gastrointestinal mesenchymal tumor.
Yasuoka R; Sakakura C; Shimomura K; Fujita Y; Nakanishi M; Aragane H; Hagiwara A; Bamba M; Abe T; Yamagishi H
Dig Surg; 2003; 20(3):183-91. PubMed ID: 12759497
[TBL] [Abstract][Full Text] [Related]
2. Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas.
Lasota J; Jasinski M; Sarlomo-Rikala M; Miettinen M
Am J Pathol; 1999 Jan; 154(1):53-60. PubMed ID: 9916918
[TBL] [Abstract][Full Text] [Related]
3. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors.
Taniguchi M; Nishida T; Hirota S; Isozaki K; Ito T; Nomura T; Matsuda H; Kitamura Y
Cancer Res; 1999 Sep; 59(17):4297-300. PubMed ID: 10485475
[TBL] [Abstract][Full Text] [Related]
4. Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors.
Moskaluk CA; Tian Q; Marshall CR; Rumpel CA; Franquemont DW; Frierson HF
Oncogene; 1999 Mar; 18(10):1897-902. PubMed ID: 10086344
[TBL] [Abstract][Full Text] [Related]
5. c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant.
Wardelmann E; Neidt I; Bierhoff E; Speidel N; Manegold C; Fischer HP; Pfeifer U; Pietsch T
Mod Pathol; 2002 Feb; 15(2):125-36. PubMed ID: 11850541
[TBL] [Abstract][Full Text] [Related]
6. Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors.
Wardelmann E; Losen I; Hans V; Neidt I; Speidel N; Bierhoff E; Heinicke T; Pietsch T; Büttner R; Merkelbach-Bruse S
Int J Cancer; 2003 Oct; 106(6):887-95. PubMed ID: 12918066
[TBL] [Abstract][Full Text] [Related]
7. Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases.
Lasota J; Wozniak A; Sarlomo-Rikala M; Rys J; Kordek R; Nassar A; Sobin LH; Miettinen M
Am J Pathol; 2000 Oct; 157(4):1091-5. PubMed ID: 11021812
[TBL] [Abstract][Full Text] [Related]
8. C-kit gene mutation in human gastrointestinal stromal tumors.
Hou YY; Tan YS; Sun MH; Wei YK; Xu JF; Lu SH; A-Ke-Su SJ; Zhou YN; Gao F; Zheng AH; Zhang TM; Hou WZ; Wang J; Du X; Zhu XZ
World J Gastroenterol; 2004 May; 10(9):1310-4. PubMed ID: 15112348
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases.
Miettinen M; Furlong M; Sarlomo-Rikala M; Burke A; Sobin LH; Lasota J
Am J Surg Pathol; 2001 Sep; 25(9):1121-33. PubMed ID: 11688571
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal stromal tumors with exon 8 c-kit gene mutation might occur at extragastric sites and have metastasis-prone nature.
Ito T; Yamamura M; Hirai T; Ishikawa T; Kanda T; Nakai T; Ohkouchi M; Hashikura Y; Isozaki K; Hirota S
Int J Clin Exp Pathol; 2014; 7(11):8024-31. PubMed ID: 25550846
[TBL] [Abstract][Full Text] [Related]
11. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review.
Miettinen M; Majidi M; Lasota J
Eur J Cancer; 2002 Sep; 38 Suppl 5():S39-51. PubMed ID: 12528772
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course.
Lasota J; Dansonka-Mieszkowska A; Stachura T; Schneider-Stock R; Kallajoki M; Steigen SE; Sarlomo-Rikala M; Boltze C; Kordek R; Roessner A; Stachura J; Miettinen M
Mod Pathol; 2003 Dec; 16(12):1257-64. PubMed ID: 14681327
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors.
Kim TW; Lee H; Kang YK; Choe MS; Ryu MH; Chang HM; Kim JS; Yook JH; Kim BS; Lee JS
Clin Cancer Res; 2004 May; 10(9):3076-81. PubMed ID: 15131046
[TBL] [Abstract][Full Text] [Related]
14. Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors.
Antonescu CR; Sommer G; Sarran L; Tschernyavsky SJ; Riedel E; Woodruff JM; Robson M; Maki R; Brennan MF; Ladanyi M; DeMatteo RP; Besmer P
Clin Cancer Res; 2003 Aug; 9(9):3329-37. PubMed ID: 12960119
[TBL] [Abstract][Full Text] [Related]
15. Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours.
Hirota S; Nishida T; Isozaki K; Taniguchi M; Nakamura J; Okazaki T; Kitamura Y
J Pathol; 2001 Apr; 193(4):505-10. PubMed ID: 11276010
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors.
Singer S; Rubin BP; Lux ML; Chen CJ; Demetri GD; Fletcher CD; Fletcher JA
J Clin Oncol; 2002 Sep; 20(18):3898-905. PubMed ID: 12228211
[TBL] [Abstract][Full Text] [Related]
17. KIT gene deletions at the intron 10-exon 11 boundary in GI stromal tumors.
Corless CL; McGreevey L; Town A; Schroeder A; Bainbridge T; Harrell P; Fletcher JA; Heinrich MC
J Mol Diagn; 2004 Nov; 6(4):366-70. PubMed ID: 15507676
[TBL] [Abstract][Full Text] [Related]
18. Exon 11 homozygous mutations and intron 10/exon 11 junction deletions in the KIT gene are associated with poor prognosis of patients with gastrointestinal stromal tumors.
Shen YY; Ma XL; Wang M; Zhuang C; Ni B; Tu L; Liu Q; Zhao WY; Cao H
Cancer Med; 2020 Sep; 9(18):6485-6496. PubMed ID: 32697050
[TBL] [Abstract][Full Text] [Related]
19. KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size.
Corless CL; McGreevey L; Haley A; Town A; Heinrich MC
Am J Pathol; 2002 May; 160(5):1567-72. PubMed ID: 12000708
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features of gastric stromal tumors.
Nishida T; Nakamura J; Taniguchi M; Hirota S; Ito T; Kitamura Y; Matsuda H
J Exp Clin Cancer Res; 2000 Dec; 19(4):417-25. PubMed ID: 11277317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
